Preparing for IPO: Financial and Valuation Risks for Life Sciences Companies and How to Address Them
June 4, 2026
10:00 am - 10:50 am
Getting to IPO is only half the challenge. For life sciences companies, the financial, operational, and governance decisions made today directly shape valuation outcomes tomorrow – and the gaps that go unaddressed can delay your timeline or create drag when it matters most.
Join us for Preparing for IPO: Financial and Valuation Risks for Life Sciences Companies and How to Address Them, where we’ll cover the checklist and dive deeper into the following:
- How to clean up your cap table before it becomes a dealbreaker
- What to fix in your convertible notes and instruments before diligence
- How to get your ASC 718 compliance right the first time
- Why a strong valuation position is your best defense in diligence
Walk away with a practical framework to assess where your company stands today, identify the risks that could derail your timeline or valuation, and build a clear roadmap to get IPO-ready before advisor decisions and valuation targets are locked in.
CPE credit will be offered for this session.
